Week 3: DKA & HHS
Overview of Content
Fluid and Electrolyte Regulation
Define processes regulating the movement of water and electrolytes.
Describe etiology, diagnostic findings, clinical manifestations, and nursing management of associated disorders.
Identify acid-base balance maintenance processes.
Discuss associated acid-base imbalances.
Describe composition and indications of common IV fluid solutions.
Discuss types and nursing management of central venous access devices.
Fluid Types
Quick Review
Isotonic
Expands extracellular fluid (ECF) and intravascular space.
Examples: 0.9% Normal Saline (NSS), Lactated Ringer's Solution, D5W.
Hypotonic
Contains more water than electrolytes.
Causes movement of water from ECF to intracellular fluid (ICF).
Example: 0.45% NSS.
Hypertonic
Pulls fluid into ECF, increases blood pressure.
Risk of vascular fluid overload.
Examples: D5 0.45% NSS, D5 0.9% NSS, D10%, 3% NSS.
Fluid and Electrolytes
Dehydration
Defined as fluid loss leading to electrolyte concentration increase.
Hypovolemia
Represents loss of both fluids and electrolytes.
Fluid Retention
Describes a decrease in electrolyte concentration due to excess body fluid.
Hypervolemia
Characterized by increases in body fluids and sodium balance.
Electrolyte Disturbances
Causes of Electrolyte Increase
Retention, decreased excretion, excessive ingestion, fluid loss.
Causes of Electrolyte Decrease
Increased excretion, inadequate ingestion, fluid overload dilution.
Normal Ranges for Key Electrolytes
Potassium: 3.5-5.0 mEq/L
Phosphorous: 2.5-4.5 mg/dL
Sodium: 135-145 mEq/L
Calcium: 8.5-10.5 mg/dL
Magnesium: 1.8-3.0 mg/dL.
Administration of Potassium
Key Rules
Infusion: Never give IV push; always dilute.
Push is given to prison for deaath penalty.
Dosage: Administer 10-20 mEq per hour.
Sample order: 40 mEq KCL in 500 mL D5W over 4 hours.
Preference for central line administration.
Diabetes Overview
Pathophysiology
Affects carbohydrate, fat, and protein metabolism related to insulin and glucagon imbalances.
Both Type 1 and Type 2 diabetes are characterized by hyperglycemia.
These clients are very dehydrated.
The water is coming in and out because the glucose isn’t using it, thus this is why clients have polydipsia and polyuria.
Symptoms of Diabetes
Classic Symptoms
Polydipsia (excessive thirst)
Polyuria (increased urination)
Polyphagia (increased hunger) due to alternative energy utilization (fat, then protein) when glucose is unavailable.
Type 1 Diabetes Characteristics
Accounts for <10% of all diabetics.
Autoimmune disease with viral triggers is primarily diagnosed in children and young adults.
Abrupt onset with weight loss; presence of urine ketones; no endogenous insulin production.
Glycolysis: the metabolic pathway that converts glucose into pyruvate, producing ATP and NADH, plays a crucial role in energy metabolism, particularly under conditions of insulin deficiency common in DKA.
Proteinloysis: The breakdown of proteins into amino acids occurs, leading to further metabolic complications in patients.
Both contribute to ketones in urine.
Type 2 Diabetes Characteristics
Most prevalent type (80-90% of diabetics).
Strong genetic component, often linked to obesity, predominantly occurs after age 45 (most common over age 65).
Insidious onset; insulin resistance developed; ketoacidosis is not typical.
Insulin Types and Their Characteristics
Rapid-acting
Onset: 5-15 min
Peak: 45-75 min
Duration: 2-4 hrs
Used for meals or acute hyperglycemia.
Short-acting (Regular; given in DKA)
Onset: 30-60 min
Peak: 2-4 hrs
Duration: 5-8 hrs
Used for meals or acute hyperglycemia.
Intermediate-acting
Onset: 1-2 hrs
Peak: 4-12 hrs
Duration: 18-24 hrs.
Long-acting (Glargine)
Onset: 2 hrs
No peak
Duration: 24 hrs.
Long-acting (Detemir)
Onset: 2 hrs
Peak: 3-9 hrs
Duration: 6-24 hrs.
Diabetic Ketoacidosis (DKA)
Acute Complication of Uncontrolled Diabetes
Fatal if left untreated.
Characterized by hyperglycemia, dehydration, electrolyte loss (K+ and Na), hyperkalemia, ketosis, and metabolic acidosis (only in DKA).
DKA Etiology and Pathophysiology
Primary Clinical Features
Presence of hyperglycemia, dehydration, hyperkalemia, ketosis, and metabolic acidosis.
Clinical Manifestations of DKA
Symptoms can be nonspecific and mistaken for other conditions:
Flushed, warm, and dry skin.
Lethargy and decreased level of consciousness (LOC).
Blurred vision.
Hypotension and tachycardia.
Severe abdominal pain, nausea, vomiting (GI upset with DKA due to the glycolysis going on).
Polyuria and polydipsia occurred 1-3 days prior.
Hyperventilation with Kussmaul respirations and fruity odor on breath (related to compensation for metabolic acidosis).
DKA Laboratory Findings
Serum glucose: 250-600 mg/dL
Serum potassium: can be high, low, or normal
Blood pH: 6.8-7.3
Give bicarbonate (IV push or drip) if the pH is less than 7.
Serum bicarbonate: <15 mEq/L
Serum sodium: 130-140 mEq/L
BUN: mildly elevated
Serum and urine ketones: increased.
Anion Gap Metabolic Acidosis
Definition:
Serum anion gap is determined using the formula:
Serum sodium - (serum chloride + bicarbonate).
In DKA, the anion gap may be higher than 20 mEq/mL.
Normal is between 3-10.
Anything over 12 is considered a gap; consider metabolic acidosis.
Goals of DKA Management
Correct fluid and electrolyte imbalances
Provide adequate insulin for glucose metabolism
Correct acidosis
Prevent complications
Goal #1: Correct Fluid and Electrolyte Imbalances
Initial IV fluid replacement with normal saline (NS) at a rate of 1 liter/hour until blood pressure stabilizes and urine output > 60 mL/hour.
May get 1 or more liters based on lab values.
After the first liter, switch to half normal saline at 300-500 mL/hour until glucose levels decrease.
When glucose is <250, change to D5 0.45% saline (hypertonic) to ensure continued insulin administration without hypoglycemia.
Once until <200-180, then the client can start eating and drinking.
Potassium Monitoring in DKA
Potassium levels: Initial high values expected due to movement out of cells.
Monitor serum K+ frequently post-hydration and insulin therapy initiation as levels can decline.
Goal #2: Provide Adequate Insulin
Initial IV bolus: 0.15 units/kg, followed by continuous infusion at 0.1 units/kg.
Monitor blood glucose every hour; if no change after 1 hr, double the infusion rate.
Prevent a decrease in glucose by more than 50-100 mg/hour to avoid complications such as cerebral edema.
Upon blood glucose <250 mg/dL, reduce insulin infusion by half and switch to sliding scale therapy.
Sliding scale while still on the drip to prevent rebound hyperglycemia and maintain stable glucose levels.
Goal #3: Correct Acidosis
Routine bicarbonate administration is not advised; acidosis resolves with insulin’s action.
If pH < 7.0, a slow IV infusion of bicarbonate may be given over several hours.
Goal #4: Prevent Complications
Monitor and promptly address:
Cardiac arrhythmias.
Electrolyte imbalances (hyper/hypokalemia).
Cerebral and pulmonary edema.
Hypoglycemia.
Acute renal failure.
Patient Teaching for DKA
Emphasize adherence to treatment regimens, especially during illness:
Do not stop insulin/hypoglycemic agents when sick (sick day rules).
Prioritizing hydration and checking sugar more often.
Maintain oral intake of fluids and carbohydrates.
Check blood glucose and ketones every 4 hours.
Contact healthcare provider if unable to take PO or if urine ketones are positive or BG is elevated.
Hyperglycemic Hyperosmolar Syndrome (HHS)
Higher mortality rate than DKA (20-40%).
Gradual onset over days to weeks (DKA occurs within a few hours).
Hallmarks: Severe hyperglycemia, profound dehydration, and lack of ketosis.
No change in pH.
Occurs more likely in Type 2, especially in those who don’t drink water.
HHS Etiology and Pathophysiology
More common in type II diabetics, frequently triggered by illness or stress.
Most prevalent in older, obese diabetics with impaired thirst and decreased renal function.
May also occur in patients previously undiagnosed with diabetes, sometimes precipitated by medications like steroids or thiazides.
What's Happening in HHS?
Major differentiation from DKA: No ketonuria, as the patient retains some insulin secretion.
Despite insulin secretion, glucose transport into cells is inadequate, leading to hyperglycemia.
HHS Clinical Manifestations
Gradual symptom onset (you’d notice more signs of dehydration):
Polydipsia, polyuria, sugar cravings.
Weight loss, dry mucous membranes, poor skin turgor, pallor.
Weakness, fatigue, lethargy, coma.
Hypotension, tachycardia.
Dyspnea without fruity breath.
Mild abdominal pain.
HHS Laboratory Findings
Serum glucose: 600-2000 mg/dL.
Serum ketones: normal or mildly elevated.
Serum pH: normal or mild acidosis (pH > 7.25).
Serum Na+: normal or elevated.
Bicarbonate: normal.
Serum K+: normal, low, or elevated.
BUN: >80 mg/dL.
Higher chance of kidney injury due to fluid imbalances.
Serum osmolality: >400 (normal 285-295).
Nursing Care for HHS
Primary Intervention: Rapid rehydration, with deficits potentially exceeding 10 liters.
Administer NS 2L during the first hour, followed by D5 0.45% saline for the next 6-10L.
When glucose reaches 250-300 mg/dL, switch to D5 1/2 NS.
IV Insulin Administration in HHS
Low-dose insulin to facilitate cellular glucose uptake and decrease serum osmolality.
Potassium Replacement: Needed as rehydration occurs; however, loss is generally less than in DKA.
Bicarbonate therapy is not necessary in HHS management.
Comparison between DKA and HHS
Patients Affected:
DKA: Type 1 diabetes (can also occur with Type 2).
HHS: Type 2 diabetes, especially in the elderly.
Precipitating Events:
DKA: Omission of insulin or stress (infection, surgery, stroke, MI).
HHS: Physiologic stressors.
Onset:
DKA: Rapid (less than 24 hours).
HHS: Slower (days).
Blood Glucose Levels:
DKA: Usually over 250 mg/dL.
HHS: Usually over 600 mg/dL.
Arterial pH Level:
DKA: Below 7.3
HHS: Typically normal.
Serum and Urine Ketones:
DKA: Present
HHS: Absent.
Serum Osmolality:
DKA: 300-350 mOsm/L
HHS: Greater than 350 mOsm/L.
Plasma Bicarbonate Level:
DKA: Less than 15 mEq/L
HHS: Normal.
BUN and Creatinine Levels:
Both conditions are elevated.
Mortality Rate:
DKA: Less than 5%
HHS: 10-40%.